Loading transcript...
Click for full transcript
Chapters & Sections (208)
▼
0:00
Symposia Group's Anti-Csychedelic Reporting and Behavior
2:01
Hamilton Morris' Work on Psychoactive Drugs and New Discoveries
3:34
The Growing Interest in Psychedelics and Therapeutic Settings
4:35
Legacy Media's Failure to Cover Drug Issues
6:38
Company Size and Location Changes
7:08
Vice's Counterculture Literary Magazine Era
7:41
Pivot to News and Journalism
09:47
The Shift to Independent Journalism
10:49
Fact-Checking and Legal Liability
11:21
The Importance of Freedom to Speak
12:51
Therapy Success and FDA Rejection
13:23
External Pressure and Schedule One Narcotic Status
13:55
Paid Protesters and Alternative Media Complicity
14:26
Psychedelic World Turn and Legal Threats
15:59
Industry Autopilot and Negative Articles
16:30
Entrepreneurship of Psychedelic Negativity
17:00
Gentrification of Consciousness and Critique of Capitalism
18:03
Moralistic Hand-Ringing and Anti-Veteran Sentiment
19:04
Patent scaremongering and its impact on the conversation
20:05
The absurdity of patent enforcement for DMT vapes
21:07
Real issues overshadowed by misinformation and distractions
22:10
Concerns about Patent Infringement and Federal Prohibition
23:13
Anti-Cyberdelic Reporting and Online Harassment
24:15
Personal Experience with Symposia and Allegations of Impropriety
25:16
Parable of the Left Eating Itself and Real Problems in Psychedelic Research
25:48
Unethical Behavior and Support for Eona
26:19
Terrorizing and Simplistic Morality in Psychedelic Advocacy
26:51
Mainstreaming Psychedelics and Gatekeepers
27:22
Conflict of Interest and Unfair Practices in Psychedelic Journalism
28:24
Misinformation and Manipulation of Psychedelic Research
28:55
False Allegations of Interference and Misleading Reporting
29:57
Double Gaslighting by Pharmaceutical Company Eona
30:28
Funding and Conflicts of Interest in Journalism
30:58
Eona's Tactics to Discredit Rival Company Compass and Block Legalization
32:00
EONA's Potential Manipulation of Public Opinion
32:32
Opposing Huntington Life Science and EONA's Tactics
33:03
Paid Protest and Controlled Opposition
34:36
Question on Psilocybin Polymorph Patent and Supply Chain Impact
35:07
Lack of Indigenous Knowledge in Synthetic Tryptophanes
35:38
Criticisms and Personal Feelings
36:11
Toxicology and Venom/Poison Distinction
37:43
Eona Employee's Criticism and Association with Compass
38:14
Conflict of Interest in Pharmaceutical Company Funding
38:46
Complex Corporate Structure and Patent Manipulation
39:16
Billionaires' Self-Interest and Obfuscation
40:19
Criticism of Symposia and Travis Kitchens' Anti-Drug Research
41:22
Eona's involvement with Symposia and potential corruption
41:55
Confrontation about Eona's funding of Symposia
42:26
Accusations of financial support for anti-Compass efforts
42:59
Defending the donations and potential motivations
43:29
Discussion of the Sarlo family foundation's involvement
44:00
Defamation and truth as a defense
44:30
Funding Extremist Groups and Uncontrollable Individuals
45:00
Patents as Magic Spells and Historical Lessons
45:30
MDMA Therapy Rejection and Complicated Story
46:04
Rick Dolin's Quest to Reverse MDMA Prohibition
47:37
Rick's Efforts to Create a Safe Therapeutic Environment
48:09
Therapist-Patient Relationship and Abuse Incident
48:39
Symposia's Exploitation of the Situation and Manipulation of the FDA
50:46
Concerns about Harms and Misconduct with MDMA Therapy
51:16
False Allegations of Therapist Misconduct
52:19
Fabricated Incident and Public Humiliation
53:55
The Importance of Independent Reporting and Ground News
54:26
Biased Coverage of FDA's Rejection of MDMA
54:57
Left-Wing Backpedaling and Media Manipulation
55:28
Ground News Features and Importance of Critical Thinking
56:30
Limitations of the Clinical Trial
57:01
Abuse Potential and Addiction Concerns
57:31
Challenges Faced by Journalists
58:01
Risks and Legal Consequences for Researchers
58:32
FDA Ruling and Personal Reaction
59:33
The Injustice of MDMA Rejection
1:00:05
Prohibition Mechanisms and DEA Headquarters
1:00:36
Government Prohibition and Narcissism
1:01:07
Left-Right Infighting and Lack of Cohesion
1:02:38
The Rich Holocaust Survivor's Involvement and Potential Motives
1:03:11
Eona's Deeper Agenda and Company Rivalry
1:03:41
The Pharmaceutical Industry's Profit Motivation and Company Behavior
1:04:11
Complicated Reasons for the FDA's Delay in Approving MDMA
1:05:13
Legal Threats and Anti-Sychedelic Organizations
1:05:44
Satanic Panic and Children's Safety
1:06:46
Personal Experience with Psychedelics and HPPD
1:07:47
Russian Roulette of Psychedelics and Psychosis Risk
1:08:49
Harms and Dangers of HPPPD
1:09:20
Rarity and Types of HPPPD
1:09:50
Impact on Functioning and Acceptance of HPPPD
1:10:22
Personal Experience with HPPPD and Search for Cures
1:11:23
Exploring Alternative Psychedelics and their Potential
1:11:54
Personal Experiences with Psychedelics and their Effects
1:12:24
Challenges in Synthesizing Psychedelics and the Quest for a Tallarium
1:12:55
Salvia and its Potential Modifications
1:14:29
Challenges in Making LSD and Synthetic Drugs
1:15:31
Difficulty of Synthesis and Precursor Materials
1:16:01
Risks and Dangers of Synthetic Drugs
1:17:35
Personal Experience with International Data
1:18:07
Benefits of SY's EIM Plans
1:18:38
Coupon Code and Discount Offer
1:20:12
The Problem with Medicalizing Substance Use
1:20:42
Comparison to Recreational Use and the Risk of Dependence
1:21:13
Ketamine's Legal Status and Off-Label Use
1:22:15
Psychedelic Legality and the Concerns of Federal Intervention
1:23:17
Ineffective Drug Prohibition and Alternative Strategies
1:23:48
Abolishing the DEA and Regulated Markets
1:24:18
Harm Reduction Facilities and Regulation
1:24:49
Treatment Programs and Societal Conceptualization of Drug Use
1:25:53
Dr. Manglo's Psychosurgical Procedure and Criticism
1:26:25
Alternative Methods for Treating Cocaine Addiction
1:27:26
Normalization of Drug Use and Regulation
1:28:28
Initial Thoughts on Psychedelics and Their Portrayal in Media
1:28:58
Ibogga and Its Cultural Significance
1:29:30
Personal Experience with Ibogga and Comparison to Other Psychedelics
1:30:01
Cautious Approach to Trying New Psychedelics and the Potential of HPPPD
1:31:05
Avoiding Visual Stimuli in Psychedelic Experiences
1:31:38
HPPD Disclosure Movement and Responsibility
1:32:09
Unique Position of Introducing New Substances
1:32:40
Responsibility in Promoting Obscure Drugs
1:33:41
The Consequences of Prohibition and the Importance of Cautious Discussion
1:34:13
The Lack of Evidence for DOI's Use and Abuse
1:34:43
The Importance of Scientific Evidence in Decision-Making and the Dangers of Self-Censorship
1:36:16
Criticizing Vice's Business Model and Priorities
1:36:48
Personal Reflections on Vice and Career Choices
1:37:19
Gratitude for Opportunities at Vice and Concerns about Company's Future
1:38:49
Analysis of Factors Contributing to Vice's Collapse
1:39:20
Coasting on Coolness and Underpayment
1:39:51
Manipulation and Lack of Recognition of Worth
1:40:22
Overpaying Executives and Underpaying Employees
1:40:52
Resistance to Supporting the Show and Crazy Freedom
1:42:27
Fame and Public Perception of Celebrities
1:42:57
Toxic Gossip and Public Backlash
1:43:28
Counterculture and the Downfall of Vice
1:43:59
Resentment and Bureaucracy within Vice
1:44:30
Personal Experiences and Criticism of Vice
1:45:00
Vice's Evolution and Creative Freedom
1:45:32
Documentary on MDMA Production
1:46:03
Advertising Campaign and Accessibility of MDMA
1:46:34
Personal Experience with MDMA and Shame
1:47:05
Regret and Unresponsibility during Comeup
1:47:38
MDMA Use at Burning Man and Unintended Consequences
1:48:40
Zeno Project Experience and Critique of Vice's Approach to Propaganda
1:49:43
Vice's Request for Article and Critique of Pharmaceutical Propaganda
1:50:14
Importance of Transparency and Accountability in Journalism
1:51:14
Personal Biases and Greyhound Racing
1:52:16
Conflict of Interest with Informants
01:53:50
Personal Opinion on Abortion
01:54:20
Critique of Anti-Abortion Movement
01:54:51
Fear of DMT Patents and Misdirected Energy
01:55:23
Symposia's Impact on MDMA Legalization
01:55:53
Rick Doblin and Joe Rogan Controversy
1:56:56
Symposia's Involvement in Harassment and Controversy
1:57:26
Individuals Involved in Harassment and Controversy
1:58:28
Consequences of Symposia's Actions and Allies
02:00
Michael Pollen's Publication and Passive Aggressive Coverage
02:31
Symposia's Motivations and Funding
02:03:06
Therapy Framework and Discourse Poisoning
02:03:38
Underground Therapy Risks and Lack of Resources
02:04:08
Therapeutic Transgressions and Accountability
02:04:40
Abuse of Power and Manipulation
02:06:12
Concerns about Non-Profits and Manipulation
02:06:43
Journalistic Failure and Suppression of Information
02:07:14
Warning about the News and Critical Thinking
3h 16m⏭ 6
1h 41m⏭ 2
1h 31m⏭ 2
1h 24m⏭ 1
1h 42m⏭ 2
1h 51m⏭ 3
38m
1h 48m⏭ 2
22m⏭ 1
1h 4m⏭ 1
46m⏭ 2
1h 0m
48m⏭ 1
1h 20m
1h 40m⏭ 3
31m⏭ 1
4h 6m⏭ 2
1h 22m
1h 16m⏭ 4
1h 50m⏭ 3
1h 0m⏭ 1
1h 28m⏭ 2
47m
18m